Chief Scientist
Wilmar (Shanghai) Biotechnology Research & Development Center Co. Ltd.
Shanghai , Shanghai, China
Xuebing Xu, Chief Scientist of Yihai Kerry Group (Wilmar China). He was the general manager of Wilmar (Shanghai) Biotechnology Research and Development Center Co. Ltd. and director of the group R&D for 12 years. He obtained a BSc in Food Technology from Henan University of Technology in 1984, China. He obtained his Ph.D. in chemical engineering from the Technical University of Denmark (DTU) in 1999. He was hired as an associate professor in DTU from 2001 and the full professor in Aarhus University, Denmark, from 2008. His research interests include lipid technology, enzyme technology, food functionality, food safety, flavor chemistry, functional lipids, etc. He has 370 publications including 240 SCI papers and 35 book chapters. He is the editor or co-editor of 4 books and the inventor or co-inventor of more than 90 patents. Xuebing Xu received a list of awards including European Lipid Technology Award from the European Federation of Lipids; Honored Student Award, AOCS Fellow, and AOCS Stephen Chang Award from the American Oil Chemists’ Society; Research Excellence Award and 3 project awards in Grand Prize and First Prize from the Chinese Cereals and Oils Association; Lifetime Achievement Award from the International Association for Rice Bran Oil; Magnolia Memorial Award from Shanghai City; etc. Xuebing Xu was/is an honorary professor for several universities globally. He served the Governing Board of AOCS for two terms and Phospholipids Division chair for one term. He has been served as associate editor for JAOCS since 2005 and is currently served as the chair for AOCS China Section.
Disclosure information not submitted.
Monday, April 28, 2025
8:30 AM – 10:00 AM PST
Monday, April 28, 2025
8:30 AM – 10:00 AM PST
Rice bran oil: nature’s gift to mankind
Monday, April 28, 2025
8:35 AM – 8:55 AM PST
Lipids for infant formula: development for chemically and physically mimicking human milk
Monday, April 28, 2025
1:35 PM – 2:15 PM PST
Pre-clinical and clinical studies of structured triacylglycerols (OPO and OPL) in human milk
Wednesday, April 30, 2025
9:35 AM – 9:55 AM PST